MYCN and poikiloderma with neutropenia: Foxa2, a major regulator of cell fate decision commonly overexpressed in NEPC, was hypomethylated, upregulated, and preferentially bound by N-Myc near its TSS in PRN tumors compared to PN tumors (Fig. 7e).